Technical Analysis for THOR - Synthorx, Inc.

Grade Last Price % Change Price Change
grade B 18.66 -0.53% -0.10
THOR closed down 0.53 percent on Friday, September 20, 2019, on 4.83 times normal volume.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Up Flat
See historical THOR trend table...

Date Alert Name Type % Chg
Volume Surge Other 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Doji - Bearish? Reversal 0.00%
Upper Bollinger Band Walk Strength 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Upper Bollinger Band Touch Strength 0.00%
Pocket Pivot Bullish Swing Setup -0.53%
Bollinger Band Squeeze Range Contraction -0.53%
BB Squeeze + Upper Band Touch Range Contraction -0.53%
Upper Bollinger Band Touch Strength -0.53%

Older signals for THOR ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Synthorx, Inc. is a biotechnology company focused on prolonging and improving the lives of people with cancer and autoimmune disorders. Synthorx’s proprietary, first-of-its-kind Expanded Genetic Alphabet platform technology expands the genetic code by adding a new DNA base pair and is designed to create optimized biologics, referred to as Synthorins. A Synthorin is a protein optimized through incorporation of novel amino acids encoded by the new DNA base pair that enables site-specific modifications, which enhance the pharmacological properties of these therapeutics. The company’s lead product candidate, THOR-707, a variant of IL-2, is in development in multiple tumor types as a single agent and in combination with an immune checkpoint inhibitor. The company was founded based on important discoveries in Dr. Floyd Romesberg’s lab at The Scripps Research Institute. The company is headquartered in La Jolla, Calif.
Biotechnology Biopharmaceutical Cancer Life Sciences Biology Immune System Tumor Genetics Platform Technology Autoimmune Disorders DNA Immune Checkpoint Molecular Genetics Nucleic Acids Genetic Code
Is THOR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 23.53
52 Week Low 11.0
Average Volume 47,221
200-Day Moving Average 0.0
50-Day Moving Average 16.8958
20-Day Moving Average 18.166
10-Day Moving Average 18.648
Average True Range 1.2663
ADX 26.43
+DI 23.1227
-DI 15.5926
Chandelier Exit (Long, 3 ATRs ) 16.3111
Chandelier Exit (Short, 3 ATRs ) 20.2489
Upper Bollinger Band 19.473
Lower Bollinger Band 16.859
Percent B (%b) 0.69
BandWidth 14.389519
MACD Line 0.5887
MACD Signal Line 0.6389
MACD Histogram -0.0502
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 20.52
Resistance 3 (R3) 20.62 20.10 20.21
Resistance 2 (R2) 20.10 19.62 20.05 20.11
Resistance 1 (R1) 19.38 19.33 19.12 19.28 20.01
Pivot Point 18.85 18.85 18.72 18.81 18.85
Support 1 (S1) 18.14 18.38 17.87 18.04 17.31
Support 2 (S2) 17.61 18.09 17.56 17.21
Support 3 (S3) 16.89 17.61 17.11
Support 4 (S4) 16.80